our expertise

acCELLerate is a specialist for large-scale production and cryopreservation of highly functional assay ready cells. The instant use of cells from a frozen stock became a widely accepted approach which is preferred to the use of continuously passaged cells. Today, assay ready cells are used manifold for the screening of new drugs and functional ingredient, the animal free safety testing of chemicals, and for the potency testing of biotherapeutics in clinical development and manufacturing control. Assay ready cells increase the flexibility of any cell-based project and can significantly improve assay precision.

Based on 16 years of experience acCELLerate has developed freezing protocols and established well-controlled processes to prepare assay ready Frozen Instant Cells of high quality and robustness. Frozen Instant Cells can be used like a reagent without prior cultivation. acCELLerate provides assay ready cells from multiple cell lines, validated instaCELL bioassay kits, as well as custom cell banks of Frozen Instant Cells with comprehensive documentation to meet specific requirements of the different fields of application.

what's new

February, 2019
High density frozen instant cells prepared by acCELLerate have been successfully used for the efficient production of adeno-assocaiated viruses (AAV). The work which has just been published in "Human Gene Therapy Methods" describes an efficient and very reliable method to produce viral vectors. Click here to read the whole story

September, 2018
The new instaCELL bioassay kit to test for drug induced phospholipidosis is now available at acCELLerate. The kit contains all required reagents including assay ready HepG2 cells qualified for instant use. Get your kit here

August, 2018
acCELLerate is one of the few biotechnolgy in Northern Germany, which is training biology lab technicians. We are happy to welcome Viktoria Patzelt as our new trainee in our team.

meet acCELLerate

BEBPA US Bioassay conference
March 13-15, 2019
San Pedro (USA)

ELRIG
"Research and Innovation" 

April 2-3, 2019
Cambridge (UK)